A Personalized 14-3-3 Disease-Targeting Workflow Yields Repositioning Drug Candidates
Rare diseases typically evade the application of the standard drug discovery and development pipelines due to their understudied molecular etiology and the small market size. Herein, we report a rare disease-directed workflow that rapidly studies the molecular features of the disorder, establishes a...
Saved in:
| Main Authors: | Yonika A. Larasati, Gonzalo P. Solis, Alexey Koval, Christian Korff, Vladimir L. Katanaev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/8/559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the YWHAG gene mutations in Developmental and Epileptic Encephalopathy
by: Violet Vilmont, et al.
Published: (2025-08-01) -
YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
by: Hongmei Zheng, et al.
Published: (2025-03-01) -
A Novel YWHAG Variant L173S Causes Developmental and Epileptic Encephalopathy by Disrupting the Hydrophobic Internal Protein Structure
by: Yuan Jin, et al.
Published: (2025-04-01) -
Novel Mutation at Cys225 in GNAO1‐Associated Developmental and Epileptic Encephalopathies: Clinical, Molecular, and Pharmacological Profiling of Case Studies
by: Yonika A. Larasati, et al.
Published: (2025-05-01) -
YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway
by: Tai Tian, et al.
Published: (2024-12-01)